These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1292 related articles for article (PubMed ID: 19791840)
1. Amlodipine/valsartan single-pill combination: a review of its use in the management of hypertension. Frampton JE; Scott LJ Am J Cardiovasc Drugs; 2009; 9(5):309-30. PubMed ID: 19791840 [TBL] [Abstract][Full Text] [Related]
2. Amlodipine/valsartan/hydrochlorothiazide: fixed-dose combination in hypertension. Deeks ED Am J Cardiovasc Drugs; 2009; 9(6):411-8. PubMed ID: 19929039 [TBL] [Abstract][Full Text] [Related]
3. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension. Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820 [TBL] [Abstract][Full Text] [Related]
4. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension. Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280 [TBL] [Abstract][Full Text] [Related]
5. Single-pill combination of amlodipine and valsartan in the management of hypertension. Flack JM; Hilkert R Expert Opin Pharmacother; 2009 Aug; 10(12):1979-94. PubMed ID: 19606937 [TBL] [Abstract][Full Text] [Related]
6. Antihypertensive therapy with CCB/ARB combination in older individuals: focus on amlodipine/valsartan combination. Kostis JB Am J Ther; 2010; 17(2):188-96. PubMed ID: 19433970 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study. Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306 [TBL] [Abstract][Full Text] [Related]
8. Effective and safe reduction of blood pressure with the combination of amlodipine 5 mg and valsartan 160 mg in hypertensive patients not controlled by calcium channel blocker monotherapy. Brachmann J; Ansari A; Mahla G; Handrock R; Klebs S Adv Ther; 2008 May; 25(5):399-411. PubMed ID: 18465097 [TBL] [Abstract][Full Text] [Related]
9. Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups. Assaad-Khalil SH; Najem R; Sison J; Kitchlew AR; Cho B; Ueng KC; DiTommaso S; Shete A Vasc Health Risk Manag; 2015; 11():71-8. PubMed ID: 25653536 [TBL] [Abstract][Full Text] [Related]
10. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial. Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension. Calhoun DA; Glazer RD; Pettyjohn FS; Coenen PD; Zhao Y; Grosso A Curr Med Res Opin; 2008 Aug; 24(8):2303-11. PubMed ID: 18593517 [TBL] [Abstract][Full Text] [Related]
12. Exforge HCT. Med Lett Drugs Ther; 2009 Jun; 51(1314):47. PubMed ID: 19528888 [No Abstract] [Full Text] [Related]
13. Role of combination therapy in the treatment of hypertension: focus on valsartan plus amlodipine. Ferri C; Croce G; Desideri G Adv Ther; 2008 Apr; 25(4):300-20. PubMed ID: 18449492 [TBL] [Abstract][Full Text] [Related]
14. Amlodipine/valsartan/hydrochlorothiazide triple combination therapy in moderate/severe hypertension: Secondary analyses evaluating efficacy and safety. Calhoun DA; Crikelair NA; Yen J; Glazer RD Adv Ther; 2009 Nov; 26(11):1012-23. PubMed ID: 20024680 [TBL] [Abstract][Full Text] [Related]
16. Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: a comparative study of the efficacy and safety against amlodipine. Corea L; Cardoni O; Fogari R; Innocenti P; Porcellati C; Provvidenza M; Meilenbrock S; Sullivan J; Bodin F Clin Pharmacol Ther; 1996 Sep; 60(3):341-6. PubMed ID: 8841157 [TBL] [Abstract][Full Text] [Related]
17. Vildagliptin, a novel dipeptidyl peptidase IV inhibitor, has no pharmacokinetic interactions with the antihypertensive agents amlodipine, valsartan, and ramipril in healthy subjects. He YL; Ligueros-Saylan M; Sunkara G; Sabo R; Zhao C; Wang Y; Campestrini J; Pommier F; Dole K; Marion A; Dole WP; Howard D J Clin Pharmacol; 2008 Jan; 48(1):85-95. PubMed ID: 17986525 [TBL] [Abstract][Full Text] [Related]
18. Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy. Baser O; Andrews LM; Wang L; Xie L J Med Econ; 2011; 14(5):576-83. PubMed ID: 21728914 [TBL] [Abstract][Full Text] [Related]
19. Valsartan plus hydrochlorothiazide for first-line therapy in hypertension. Lacourcière Y; Poirier L; Samuel R Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1491-501. PubMed ID: 19954310 [TBL] [Abstract][Full Text] [Related]
20. Effects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study. Lacourcière Y; Wright JT; Samuel R; Zappe D; Purkayastha D; Black HR; Blood Press Monit; 2009 Jun; 14(3):112-20. PubMed ID: 19384192 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]